TrialBritish journal of clinical pharmacology2013

Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies.

Muhammad Baluom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.